Earnings release
Page 1
Press release - Regulated Information Melexis Q4 and FY 2025 results – Full year sales of 839.6 million EUR Intermediate declaration by the Board of Directors Ieper, Belgium – February 4th, 2026, 07.00 hrs CET CONFORM IFRS FY 2025 FY 2024 YOY change in k EUR (%) Sales 839,617 932,808 -10% Gross result 324,009 401,351 -19% Gross Margin 38.6% 43.0% EBIT 133,963 219,889 -39% EBIT in % 16.0% 23.6% EBITDA 187,302 267,630 -30% EBITDA in % 22.3% 28.7% Net result 112,505 171,446 -34% Net result per share (EPS) 2.78 4.24 CAPEX 32,443 60,574 Sales for the full year 2025 were 839.6 million EUR, a decrease of 10% compared to the previous year. The EUR/USD exchange rate evolution had a negative impact of 2% on sales compared to 2024. The gross result was 324.0 million EUR or 38.6% of sales, a decrease of 19% compared to last year. R&D expenses were 13.8% of sales, G&A was at 6.5% of sales and Selling was at 2.4% of sales. The operating result was 134.0 million EUR or 16.0% of sales, a decrease of 39% compared to 219.9 million EUR in 2024. The net result was 112.5 million EUR or 2.78 EUR per share, a decrease of 34% compared to 171.4 million EUR or 4.24 EUR per share in 2024. 1 Melexis Financial Press Release Regulated Information
Page 2
CONFORM IFRS Q4 2025 Q4 2024 YOY change Q3 2025 SEQ change in k EUR (%) (%) Sales 214,493 197,407 9% 215,287 0% Gross result 82,302 77,560 6% 83,425 -1% Gross Margin 38.4% 39.3% 38.8% EBIT 31,484 27,592 14% 37,845 -17% EBIT in % 14.7% 14.0% 17.6% EBITDA 44,562 39,974 11% 51,397 -13% EBITDA in % 20.8% 20.2% 23.9% Net result 22,575 18,279 24% 27,528 -18% Net result per share (EPS) 0.56 0.45 0.68 CAPEX 10,770 14,351 5,319 Sales for the fourth quarter of 2025 were 214.5 million EUR, an increase of 9% compared to the same quarter of the previous year and stable compared to the previous quarter. The EUR/USD exchange rate evolution had a negative impact of 3% on sales compared to the same quarter of last year and no impact on sales compared to the previous quarter. The gross result was 82.3 million EUR or 38.4% of sales, an increase of 6% compared to the same quarter of last year and a decrease of 1% compared to the previous quarter. R&D expenses were 14.5% of sales, G&A was at 6.7% of sales and Selling was at 2.5% of sales. The operating result was 31.5 million EUR or 14.7% of sales, an increase of 14% compared to the same quarter of last year and a decrease of 17% compared to the previous quarter. The net result was 22.6 million EUR or 0.56 EUR per share, an increase of 24% compared to 18.3 million EUR or 0.45 EUR per share in the fourth quarter of 2024 and a decrease of 18% compared to the previous quarter. Dividend The Board of Directors approved on February 2, 2026 to propose to the Annual Shareholders meeting to pay out over the result of 2025 a total dividend of 3.70 EUR gross per share. This amount contains an interim dividend of 1.30 EUR per share which was paid in October 2025 and a final dividend of 2.40 EUR per share which will be payable after approval of the Annual Shareholders meeting. The Melexis shares will start trading ex coupon on May 19, 2026 (opening of the market). The record date is May 20, 2026 (closing of the market) and the dividend will be payable as from May 21, 2026. Outlook Melexis expects sales in the first quarter and first half of 2026 to be around the same levels as the previous year. Sales in the second half of 2026 are expected to grow compared to the first half of 2026. For the first half of 2026, Melexis expects a gross profit margin around 40% and an operating margin around 17%, all taking into account a EUR/USD exchange rate of 1.17. For the full year 2026, Melexis expects CAPEX to be around 40 million EUR. 2 Melexis Financial Press Release Regulated Information
Page 3
Business update Sales of 214.5 million EUR in the fourth quarter of 2025 landed at the low end of the guidance, and resulted in sales of 839.6 million EUR for the full year 2025. The outperforming product lines of 2025 were motor drivers and inductive position sensors. Sales for automotive applications represented 89% of total sales in the fourth quarter of 2025, and 88% of total sales for the full year. Melexis launched 19 new products in 2025. Highlights include an inductive position sensor designed for next-generation automotive applications, particularly well suited for modern steering and braking applications including steer-by-wire implementations. We created our newest product line, protective devices, building on the company's motor control and current sensing expertise. Launching our first product, an integrated “snubber”, extends driving range by protecting and optimizing the performance of silicon carbide (SiC) power modules, designed for automotive and industrial high-voltage applications. We continue to lead innovation in automotive ambient lighting with a code-free driver. By significantly streamlining the development cycle, this solution lowers the barrier to entry for our customers and accelerates our market expansion. Quote from CEO Marc Biron "We delivered fourth quarter and full year 2025 results in line with our expectations in a challenging and unstable environment. Automotive industry demand continues to be cautious and choppy between quarters, as we remain in an uneven recovery. Looking at 2026, the first quarter is traditionally impacted by annual customer pricing agreements and seasonal factors such as Chinese New Year and sales patterns outside of automotive. In addition, this year demand is affected by recent changes in EV automotive regulations and purchase incentive schemes. We are intensifying our commercial programs with a specific focus on China and India, and are confident that these measures will improve our market position. Taking all factors into account, we see sales growing as the year progresses and profitability improving as from the first quarter. The success of Melexis relies on leveraging technology leadership to meet our customers’ needs and grow their business. Next to many new product launches in 2025 across our wide portfolio of sensors and drivers, our teams finished the year strong in terms of design wins. We also increased the amount of customer opportunities, led by China, Europe, and South Korea, positioning us well for future design wins. Progress on these key metrics is driven by automotive applications where we have leadership positions , and also in newer markets like robotics.” Quote from CFO Karen van Griensven "Actions taken during 2025 will start delivering benefits this year with a higher gross margin already in the first quarter despite stable year-on-year sales, as we navigate the recovery phase of the current demand cycle. We remain disciplined in executing our cost improvement roadmap to keep moving towards our long-term margin objectives.” The statutory auditor, PwC Bedrijfsrevisoren BV / PwC Réviseurs d’Entreprises SRL represented by Griet Helsen, acting on behalf of Griet Helsen BV, has confirmed that the audit, which is substantially completed, has not to date revealed any material misstatement in the draft consolidated accounts, and that the accounting data reported in the press release is consistent, in all material respects, with the draft consolidated accounts from which it has been derived. 3 Melexis Financial Press Release Regulated Information
Page 4
Financial Calendar - Publication Q1 2026 Results: April 29, 2026 (at 7 hrs CET) - Annual Shareholders Meeting May 12, 2026 - Dividend ex coupon date May 19, 2026 - Dividend record date May 20, 2026 - Dividend pay date May 21, 2026 - Publication Q2 2026 Results: July 29, 2026 (at 7 hrs CET) - Publication Q3 2026 Results: October 28, 2026 (at 7 hrs CET) - Publication FY 2026 Results: February 3, 2027 (at 7 hrs CET) The company’s results will be discussed in a conference call and an audio webcast on Wednesday, February 4th, 2026 at 11:00 hrs CET. To register for the conference call (possibility to ask questions) The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call. To register for the audio webcast (no possibility to ask questions) You can register for the audio webcast by clicking here. For more information: Investors Investor Relations Email: investor@melexis.com Journalists Brand & Communications Email: brandcomms@melexis.com About Melexis Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable and sustainable. Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering and battery solutions for the automotive sector. It also expands its presence in the emerging markets of sustainable world, alternative mobility, robotics, and digital health. Founded in 1989 in Belgium, Melexis has grown to employ over 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide. For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube. 4 Melexis Financial Press Release Regulated Information
Page 5
Disclaimer Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward- looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital. 5 Melexis Financial Press Release Regulated Information
Page 6
Consolidated income statement CONFORM IFRS Quarter ended Quarter ended Year ended Year ended 31/12/2025 31/12/2024 31/12/2025 31/12/2024 in k EUR audited audited Sales 214,493 197,407 839,617 932,808 Cost of sales -132,191 -119,847 -515,608 -531,457 Gross result 82,302 77,560 324,009 401,351 R&D -31,112 -30,227 -115,897 -110,252 G&A -14,433 -14,157 -54,332 -51,367 Selling -5,273 -5,584 -19,818 -19,842 Operating result (EBIT) 31,484 27,592 133,963 219,889 Financial result -2,968 -8,098 1,932 -14,568 Result before taxes 28,516 19,494 135,895 205,321 Income taxes -5,942 -1,214 -23,390 -33,875 Net result 22,575 18,279 112,505 171,446 Net result per share in EUR 0.56 0.45 2.78 4.24 Consolidated statement of financial position CONFORM IFRS Year ended Year ended 31/12/2025 31/12/2024 in k EUR audited audited Current Assets : Cash and cash equivalents 34,633 32,681 Current investments — — A/R Trade 107,852 102,246 Assets for current tax 27,727 18,889 Other current assets 108,805 55,961 Inventories 300,329 262,815 Total current assets 579,347 472,593 Non-current assets : Property, plant and equipment 196,956 211,120 Leased assets 7,583 8,801 Intangible fixed assets 1,197 1,175 Other non-current assets 82,819 163,581 Deferred tax assets 35,367 36,985 Total non-current assets 323,922 421,663 Total assets 903,269 894,255 6 Melexis Financial Press Release Regulated Information
Page 7
CONFORM IFRS Year ended Year ended 31/12/2025 31/12/2024 in k EUR audited audited Current liabilities : Derivative financial instruments 284 228 Current portion of LT debt 13,022 5,797 Lease liabilities 2,116 2,143 A/P trade 51,054 63,203 Accrued taxes 6,706 3,220 Short-term employee benefits accruals 22,523 18,222 Other current liabilities 5,902 9,320 Deferred income 4,445 2,076 Total current liabilities 106,052 104,210 Non current liabilities : LT debt less current portion 301,278 207,525 Lease liabilities 5,623 6,714 Deferred tax liabilities 2,673 3,737 Other non-current liabilities 3,115 4,567 Total non current liabilities 312,688 222,544 Shareholders' equity : Shareholders' capital 565 565 Treasury shares -50,031 -4,410 Legal reserve 57 57 Retained earnings 427,102 403,160 Current period's profit 112,505 171,446 Cumulative translation adjustment -5,669 -3,316 Equity attributable to company owners 484,529 567,501 Non controlling interests — — Total shareholders equity 484,529 567,501 Total liabilities, shareholders' equity and minority interests 903,269 894,255 7 Melexis Financial Press Release Regulated Information
Page 8
Consolidated statement of cash flows CONFORM IFRS Quarter ended Quarter ended Year ended Year ended 31/12/2025 31/12/2024 31/12/2025 31/12/2024 in k EUR audited audited Cash flow from operating activities Net income 22,575 18,279 112,505 171,446 Adjustments for : Operating activities 22,174 15,545 85,266 90,640 Depreciation and amortisation 12,476 11,826 51,034 45,639 Depreciation leased assets 601 556 2,305 2,102 Other provisions -99 -72 -991 54 Deferred income 379 -2,335 2,369 -849 Financial result 2,875 4,355 7,160 9,819 Income tax expense/income 5,942 1,214 23,390 33,875 Operating profit before working capital changes 44,749 33,824 197,771 262,086 A/R, Trade -1,081 27,542 -6,063 17,961 Other current assets -2,031 -13,058 -52,844 -23,532 Other non current assets 19,447 8,862 80,762 17,652 Inventories -2,640 -12,162 -44,585 -15,335 A/P -3,436 8,263 -12,149 -16,828 Employee benefit liabilities -1,940 279 4,307 -5,471 Other current liabilities -53 799 -3,418 -3,644 Cash generated from operations 53,014 54,351 163,781 232,890 Interest paid -2,254 -2,686 -9,262 -10,750 Income tax paid -3,740 -9,548 -28,213 -48,913 Cash flow from operating activities 47,020 42,117 126,306 173,227 Cash flow from investing activities Purchase of PPE and intangible assets (netted) -8,468 -12,237 -29,364 -53,107 Interest received 60 86 178 357 Cash provided from investing activities -8,408 -12,151 -29,185 -52,750 Cash flows from financing activities Proceeds/Repayment of long-and short-term debt 36,355 25,713 100,977 28,663 Repayment leasings -580 -607 -2,206 -2,065 Dividend payment -51,874 -52,520 -147,851 -149,480 Acquisition own shares -21,277 -4,410 -45,621 -4,410 Cash provided from financing activities -37,376 -31,824 -94,699 -127,293 Effect of exchange rate changes on cash and cash equivalents 76 77 -469 148 Increase/decrease in cash and cash equivalents 1,312 -1,782 1,952 -6,668 Cash at beginning of the period 33,321 34,463 32,681 39,349 Cash at the end of the period 34,633 32,681 34,633 32,681 8 Melexis Financial Press Release Regulated Information
Page 9
Sales per Geography Q4 2025 Q4 2024 FY 2025 FY 2024 APAC 68% 64% 64% 60% Asia Pacific EMEA 26% 28% 28% 31% Europe - Middle-East - Africa NALA 6% 8% 8% 9% North America - Latin America TOTAL 100% 100% 100% 100% 9 Melexis Financial Press Release Regulated Information